Particles, whether visible or sub-visible, in a drug product are a very serious concern (e.g., obstruction of blood vessels, inducement of immunogenicity). Particles may result from external sources (e.g., dust), manufacturing (e.g., silicone oil), or interaction with the container/delivery systems (protein aggregates). This section presents papers on particle measurement, management and resultant effects.

Register below for access to our Online Technical Repository and for current customers, our Online Technical Customer Support Portal.

Non-Customer Content

Customer Content

Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.